|
C12ORF26 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.464710E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.818140E-03 |
| Normal-vs-Stage2 |
6.434000E-02 |
| Normal-vs-Stage3 |
9.522000E-03 |
| Normal-vs-Stage4 |
4.216000E-01 |
| Stage1-vs-Stage2 |
9.816800E-01 |
| Stage1-vs-Stage3 |
6.213800E-01 |
| Stage1-vs-Stage4 |
7.717600E-01 |
| Stage2-vs-Stage3 |
6.883800E-01 |
| Stage2-vs-Stage4 |
8.254400E-01 |
| Stage3-vs-Stage4 |
5.998000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.017400E-04 |
| Normal-vs-AfricanAmerican |
4.863200E-01 |
| Normal-vs-Asian |
1.240190E-01 |
| Caucasian-vs-AfricanAmerican |
1.793920E-02 |
| Caucasian-vs-Asian |
9.723200E-01 |
| AfricanAmerican-vs-Asian |
4.893200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.041520E-03 |
| Normal-vs-Female |
3.184400E-02 |
| Male-vs-Female |
3.754400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.800800E-03 |
| Normal-vs-Extreme_Weight |
1.342350E-03 |
| Normal-vs-Obese |
1.287510E-02 |
| Normal-vs-Extreme_Obese |
4.118400E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.973000E-01 |
| Normal_Weight-vs-Obese |
5.400000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.541600E-01 |
| Extreme_Weight-vs-Obese |
4.784000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.408200E-01 |
| Obese-vs-Extreme_Obese |
2.890400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.941000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.590200E-02 |
| Normal-vs-Age(61-80Yrs) |
1.986880E-04 |
| Normal-vs-Age(81-100Yrs) |
4.358400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.298000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.488000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.123700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.182200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.989000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.734800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.626770E-01 |
| Normal-VS-Type2 PRCC |
3.65719999839698E-08 |
| Normal-VS-KIRP CIMP |
1.695840E-02 |
| Normal-VS-Unclassified PRCC |
6.872200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.65120000012098E-07 |
| Type1 PRCC-VS-KIRP CIMP |
1.728820E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.462000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.787600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.474200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.810600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.62609999999819E-05 |
| Normal-vs-N1 |
3.454800E-01 |
| Normal-vs-N2 |
5.381700E-04 |
| N0-vs-N1 |
5.294100E-02 |
| N0-vs-N2 |
2.831600E-01 |
| N1-vs-N2 |
1.165550E-01 |
|
|
